Education
About Us
Working with TipRanks
Follow Us
Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719)
:0719
RESEARCH TOOLSreports
0719 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$5.00 - HK$9.46
Previous CloseN/A
Volume2.84M
Average Volume (3M)11.76M
Market Cap
HK$11.19B
Enterprise ValueHK$5.00B
Total Cash (Recent Filing)HK$1.30B
Total Debt (Recent Filing)¥896.20M
Price to Earnings (P/E)11.8
Beta0.76
Next Earnings
Aug 27, 2025EPS Estimate
0.2Last Dividend Ex-Date
Jun 27, 2025Dividend Yield0.57%
Share Statistics
EPS (TTM)0.16
Shares Outstanding195,000,000
10 Day Avg. Volume21,023,580
30 Day Avg. Volume11,757,136
Financial Highlights & Ratios
PEG Ratio1.08
Price to Book (P/B)1.16
Price to Sales (P/S)0.00
P/FCF Ratio9.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Shandong Xinhua Pharmaceutical Company Limited Class H News
PremiumCompany Announcements
Xinhua Pharmaceutical Gains Approval for Marketing License Transfer
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Ibuprofen Arginine
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Approves Key Resolutions at AGM
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Announces Final Dividend for 2024
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Heart Failure DrugOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.34%
Mutual Funds
― Other Institutional Investors
98.49% Public Companies and
Individual Investors
0719 FAQ
What was Shandong Xinhua Pharmaceutical Company Limited Class H’s price range in the past 12 months?
Shandong Xinhua Pharmaceutical Company Limited Class H lowest stock price was HK$5.00 and its highest was HK$9.46 in the past 12 months.
What is Shandong Xinhua Pharmaceutical Company Limited Class H’s market cap?
Shandong Xinhua Pharmaceutical Company Limited Class H’s market cap is HK$11.19B.
When is Shandong Xinhua Pharmaceutical Company Limited Class H’s upcoming earnings report date?
Shandong Xinhua Pharmaceutical Company Limited Class H’s upcoming earnings report date is Aug 27, 2025 which is in 33 days.
How were Shandong Xinhua Pharmaceutical Company Limited Class H’s earnings last quarter?
Shandong Xinhua Pharmaceutical Company Limited Class H released its earnings results on Apr 29, 2025. The company reported HK$0.164 earnings per share for the quarter, missing the consensus estimate of HK$0.295 by -HK$0.131.
Is Shandong Xinhua Pharmaceutical Company Limited Class H overvalued?
According to Wall Street analysts Shandong Xinhua Pharmaceutical Company Limited Class H’s price is currently Overvalued.
Does Shandong Xinhua Pharmaceutical Company Limited Class H pay dividends?
Shandong Xinhua Pharmaceutical Company Limited Class H pays a Annually dividend of HK$0.3 which represents an annual dividend yield of 0.57%. See more information on Shandong Xinhua Pharmaceutical Company Limited Class H dividends here
What is Shandong Xinhua Pharmaceutical Company Limited Class H’s EPS estimate?
Shandong Xinhua Pharmaceutical Company Limited Class H’s EPS estimate is 0.2.
How many shares outstanding does Shandong Xinhua Pharmaceutical Company Limited Class H have?
Shandong Xinhua Pharmaceutical Company Limited Class H has 195,000,000 shares outstanding.
What happened to Shandong Xinhua Pharmaceutical Company Limited Class H’s price movement after its last earnings report?
Shandong Xinhua Pharmaceutical Company Limited Class H reported an EPS of HK$0.164 in its last earnings report, missing expectations of HK$0.295. Following the earnings report the stock price went down -0.376%.
Which hedge fund is a major shareholder of Shandong Xinhua Pharmaceutical Company Limited Class H?
Currently, no hedge funds are holding shares in HK:0719
Shandong Xinhua Pharmaceutical Company Limited Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
73.83%
12-Months-Change
Fundamentals
Return on Equity
8.89%
Trailing 12-Months
Asset Growth
8.46%
Trailing 12-Months
Company Description
Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited Class H (0719) is a leading pharmaceutical company based in China, specializing in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. The company operates in various sectors, including active pharmaceutical ingredients (APIs), finished dosage forms, and over-the-counter (OTC) products. It is recognized for its robust portfolio of analgesics, anti-infectives, cardiovascular drugs, and central nervous system medications. As a prominent player in the pharmaceutical industry, Shandong Xinhua Pharmaceutical is committed to delivering high-quality healthcare solutions globally.
Technical Analysis
Ping An Insurance Company of China
―
Sino Biopharmaceutical
―
Shanghai Fosun Pharmaceutical (Group) Co
―
CSPC Pharmaceutical Group
―
China Medical System Holdings
―